Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40013466
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
02/06/2022
Statut
Classification
1.5°C
Année cible
2030
Pfizer Inc. commits to reduce absolute scope 1 and 2 GHG emissions 46% by 2030 from a 2019 base year. Pfizer Inc. commits to increase annual sourcing of renewable electricity from 9% in 2019 to 100% by 2030. Pfizer Inc. commits to reduce absolute scope 3 emissions 25% from business travel by 2025 from a 2019 base year. Pfizer Inc. commits to reduce absolute scope 3 emissions 10% from upstream transportation and distribution by 2025 from a 2019 base year. Pfizer Inc. also commits that 64% of its suppliers by spend covering purchased goods & services, will have science-based targets by 2025. *The target boundary includes biogenic emissions and removals from bioenergy feedstocks.
Statut
Commitment removedStatut
BA1.5 memberDate d'engagement
03/06/2021
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US7170811035
LEI
765LHXWGK1KXCLTFYQ30
Expired commitment
Source : Science Based Targets initiative | Données publiques